<bill session="105" type="h" number="2221" updated="2013-07-14T18:50:27-04:00">
  <state datetime="1997-07-22">REFERRED</state>
  <status>
    <introduced datetime="1997-07-22"/>
  </status>
  <introduced datetime="1997-07-22"/>
  <titles>
    <title as="introduced" type="official">To require the Secretary of Health and Human Services to take no further action on a proposed regulation relating to the use of chlorofluorocarbons in metered-dose inhalers.</title>
  </titles>
  <sponsor id="400388"/>
  <cosponsors>
    <cosponsor id="400551" joined="1997-10-30"/>
    <cosponsor id="400012" joined="1997-10-28"/>
    <cosponsor id="400018" joined="1997-09-03"/>
    <cosponsor id="400036" joined="1997-09-29"/>
    <cosponsor id="400044" joined="1998-01-27"/>
    <cosponsor id="400055" joined="1997-07-28"/>
    <cosponsor id="400500" joined="1997-10-24"/>
    <cosponsor id="400574" joined="1998-01-27"/>
    <cosponsor id="400576" joined="1997-07-25"/>
    <cosponsor id="400522" joined="1997-10-28"/>
    <cosponsor id="400091" joined="1997-10-24"/>
    <cosponsor id="400104" joined="1997-10-21"/>
    <cosponsor id="400119" joined="1997-09-04"/>
    <cosponsor id="404280" joined="1997-07-31"/>
    <cosponsor id="400544" joined="1997-07-25"/>
    <cosponsor id="400536" joined="1997-09-10"/>
    <cosponsor id="400179" joined="1997-10-07"/>
    <cosponsor id="400182" joined="1997-07-25"/>
    <cosponsor id="400197" joined="1997-10-21"/>
    <cosponsor id="400234" joined="1997-09-23"/>
    <cosponsor id="400235" joined="1997-10-24"/>
    <cosponsor id="400244" joined="1997-10-28"/>
    <cosponsor id="400252" joined="1997-10-30"/>
    <cosponsor id="400597" joined="1997-10-02"/>
    <cosponsor id="400266" joined="1997-10-28"/>
    <cosponsor id="400288" joined="1997-07-31"/>
    <cosponsor id="400311" joined="1997-07-25"/>
    <cosponsor id="400317" joined="1997-11-05"/>
    <cosponsor id="400331" joined="1997-09-09"/>
    <cosponsor id="400343" joined="1997-09-23"/>
    <cosponsor id="400365" joined="1997-11-12"/>
    <cosponsor id="400367" joined="1997-10-07"/>
    <cosponsor id="400380" joined="1997-07-22"/>
    <cosponsor id="410136" joined="1997-10-01"/>
    <cosponsor id="400504" joined="1997-10-09"/>
    <cosponsor id="410889" joined="1997-09-23"/>
    <cosponsor id="400611" joined="1997-07-31"/>
    <cosponsor id="400516" joined="1997-09-09"/>
    <cosponsor id="400427" joined="1997-10-02"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1997-07-22">
      <text>Referred to the House Committee on Commerce.</text>
    </action>
    <action datetime="1997-07-30">
      <text>Referred to the Subcommittee on Health and Environment.</text>
      <committee name="House Committee on Commerce"/>
    </action>
    <action datetime="1997-07-31">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR E1574"/>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative procedure"/>
    <term name="Air pollution control"/>
    <term name="Asthma"/>
    <term name="Chlorofluorocarbons"/>
    <term name="Commerce"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Environmental protection"/>
    <term name="Government operations and politics"/>
    <term name="International affairs"/>
    <term name="International environmental cooperation"/>
    <term name="Law"/>
    <term name="Medical supplies"/>
    <term name="Ozone layer depletion"/>
    <term name="Treaties"/>
  </subjects>
  <amendments/>
  <summary>7/22/1997--Introduced.
Directs the Secretary of Health and Human Services to: (1) take no action to promulgate a final rule on a proposed regulation of the Food and Drug Administration to designate the use of chlorofluorocarbons (CFCs) in metered-dose inhalers (MDI) as non-essential, making MDIs that use CFCs an adulterated device; and (2) focus efforts on implementing existing Montreal Protocol decisions that will facilitate a transition to CFC-free by the year 2005.</summary>
</bill>
